Go Deep
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,831 | 14.4 | 2.83 | 0.92 | 19,905.74 |
| Oct 2026 | 19,709 | 14.7 | 2.90 | 0.92 | 20,361.55 |
| Oct 2026 | 19,816 | 14.4 | 2.84 | 0.92 | 19,911.92 |
| Oct 2026 | 19,862 | 14.3 | 2.82 | 0.92 | 19,762.58 |
| Oct 2026 | 19,726 | 14.7 | 2.89 | 0.92 | 20,267.95 |
| Oct 2026 | 19,772 | 14.5 | 2.87 | 0.92 | 20,048.58 |
| Oct 2026 | 19,703 | 14.7 | 2.90 | 0.92 | 20,260.99 |
Jazz Pharmaceuticals plc Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,208,300,000.0 | 1,068,900,000.0 | 1,197,926,000.0 | 1,126,107,000.0 |
| Net Profit | 192,800,000.0 | 293,100,000.0 | 203,451,000.0 | 251,412,000.0 |
| EPS | 3.0 | 4.7 | 3.3 | 4.1 |
Jazz Pharmaceuticals plc Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 4,267,586,000.0 | 4,068,950,000.0 | 3,834,204,000.0 | 3,659,374,000.0 | — |
| Net Profit | -356,148,000.0 | 560,120,000.0 | 414,832,000.0 | -224,060,000.0 | — |
| EPS | -5.8 | 9.1 | 6.5 | -3.6 | — |
Jazz Pharmaceuticals plc Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 11,659,340,000.0 | 12,012,257,000.0 | 11,393,359,000.0 | 10,835,255,000.0 | — |
| Total Liabilities | 7,340,756,000.0 | 7,918,501,000.0 | 7,656,362,000.0 | 7,749,521,000.0 | — |
| Total Equity | 4,318,584,000.0 | 4,093,756,000.0 | 3,736,997,000.0 | 3,085,734,000.0 | — |
Owes vs Owns
Jazz Pharmaceuticals plc owed $0.57 for every $1 it owned in Jun 2026, down from $0.72 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.57× | 0.63× | 0.66× | 0.67× | 0.72× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Jazz Pharmaceuticals plc Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 20.9%Receivables 7.1%Inventory 3.6%Fixed assets (tangible) 2.2%Intangible assets 53.7%Other assets 12.5%
How it's funded — Dec 2025
Short-term debt 8.8%Long-term debt 37.1%Payables 1.0%Other liabilities 16.0%Shareholders' equity 37.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,441.9 | 2,992.9 | 1,626.3 | 881.5 |
| Receivables | 830.7 | 716.8 | 705.8 | 651.5 |
| Inventory | 417.0 | 480.4 | 597.0 | 714.1 |
| Fixed assets (tangible) | 258.7 | 227.0 | 235.0 | 301.4 |
| Intangible assets | 6,258.9 | 6,472.0 | 7,171.2 | 7,487.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1,452.1 | 1,123.2 | 1,058.1 | 799.7 |
| Liabilities & equity | ||||
| Short-term debt | 1,029.9 | 31.0 | 605.0 | 31.0 |
| Long-term debt | 4,328.4 | 6,077.6 | 5,108.0 | 5,693.3 |
| Payables | 122.1 | 77.9 | 102.8 | 90.8 |
| Other liabilities | 1,860.4 | 1,732.0 | 1,840.7 | 1,934.4 |
| Shareholders' equity | 4,318.6 | 4,093.8 | 3,737.0 | 3,085.7 |
| Net tangible assets | -1,940.3 | -2,378.3 | -3,434.2 | -4,401.4 |
Jazz Pharmaceuticals plc Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 1,355,773,000.0 | 1,395,908,000.0 | 1,092,007,000.0 | 1,271,977,000.0 | — |
| Investing Activities | -1,509,913,000.0 | -508,195,000.0 | -163,062,000.0 | -446,230,000.0 | — |
| Financing Activities | -873,380,000.0 | 20,516,000.0 | -305,254,000.0 | -529,491,000.0 | — |